| Breakdown | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 75.94B | 54.19B | 50.41B | 48.62B | 47.01B |
| Gross Profit | 20.30B | 30.99B | 23.01B | 25.91B | 24.84B |
| EBITDA | 34.55B | 34.20B | 30.41B | 29.42B | 28.42B |
| Net Income | 24.12B | 23.85B | 20.30B | 19.29B | 17.17B |
Balance Sheet | |||||
| Total Assets | 729.96B | 730.53B | 727.23B | 714.90B | 707.55B |
| Cash, Cash Equivalents and Short-Term Investments | 50.24B | 27.06B | 36.01B | 58.91B | 31.25B |
| Total Debt | 329.95B | 328.75B | 323.85B | 313.40B | 304.43B |
| Total Liabilities | 371.59B | 370.46B | 366.43B | 354.56B | 344.29B |
| Stockholders Equity | 358.37B | 360.08B | 360.80B | 360.34B | 363.26B |
Cash Flow | |||||
| Free Cash Flow | -1.04B | -12.42B | 11.11B | 8.04B | -13.88B |
| Operating Cash Flow | 30.91B | 28.92B | 27.74B | 26.58B | 22.17B |
| Investing Cash Flow | -10.77B | -17.08B | -14.05B | -10.84B | -19.19B |
| Financing Cash Flow | -25.10B | -19.91B | -9.33B | -13.40B | -11.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥603.80B | 21.68 | ― | 4.28% | 27.21% | 39.13% | |
73 Outperform | ¥405.00B | 20.82 | 6.92% | 5.16% | -27.01% | 18.03% | |
72 Outperform | ¥431.54B | 21.36 | 7.12% | 3.74% | 78.62% | 28.76% | |
70 Neutral | ¥686.66B | 20.34 | 5.51% | 4.64% | 24.10% | -30.38% | |
67 Neutral | €355.02B | 24.81 | 5.23% | 4.18% | -5.01% | ― | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
63 Neutral | ¥593.28B | 23.54 | 6.80% | 4.46% | 52.74% | 14.88% |